BioCentury | Mar 15, 2010
Company News

Chattem Inc., sanofi-aventis deal

...Chattem for $93.50 per share, or about $1.9 billion in cash (see BioCentury, Jan. 4). Chattem Inc....
BioCentury | Feb 15, 2010
Company News

Chattem, sanofi-aventis deal

...sanofi-aventis completed its previously announced tender offer for Chattem, acquiring about 18.6 million shares (90%) for...
...the remaining shares at the same price through a short-form merger (see BioCentury, Jan. 4). Chattem Inc....
BioCentury | Jan 18, 2010
Company News

sanofi-aventis, Chattem Inc., KaloBios deal

...as co-promotion rights in the U.S. Separately, sanofi-aventis began its previously announced tender offer of Chattem...
...at midnight on Feb. 8 (see BioCentury, Jan. 4). sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Chattem Inc....
BioCentury | Jan 4, 2010
Company News

Chattem Inc., sanofi-aventis deal

...sanofi-aventis will acquire consumer healthcare company Chattem for $93.50 per share, or about $1.9 billion in...
...per share, or about $1.9 billion in cash. The price is a 34% premium to Chattem's...
...on Dec. 18, 2009, the last trading day before the deal was announced. sanofi-aventis said Chattem...
Items per page:
1 - 4 of 4
BioCentury | Mar 15, 2010
Company News

Chattem Inc., sanofi-aventis deal

...Chattem for $93.50 per share, or about $1.9 billion in cash (see BioCentury, Jan. 4). Chattem Inc....
BioCentury | Feb 15, 2010
Company News

Chattem, sanofi-aventis deal

...sanofi-aventis completed its previously announced tender offer for Chattem, acquiring about 18.6 million shares (90%) for...
...the remaining shares at the same price through a short-form merger (see BioCentury, Jan. 4). Chattem Inc....
BioCentury | Jan 18, 2010
Company News

sanofi-aventis, Chattem Inc., KaloBios deal

...as co-promotion rights in the U.S. Separately, sanofi-aventis began its previously announced tender offer of Chattem...
...at midnight on Feb. 8 (see BioCentury, Jan. 4). sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France Chattem Inc....
BioCentury | Jan 4, 2010
Company News

Chattem Inc., sanofi-aventis deal

...sanofi-aventis will acquire consumer healthcare company Chattem for $93.50 per share, or about $1.9 billion in...
...per share, or about $1.9 billion in cash. The price is a 34% premium to Chattem's...
...on Dec. 18, 2009, the last trading day before the deal was announced. sanofi-aventis said Chattem...
Items per page:
1 - 4 of 4